 Home > Active Ingredient News > Immunology News > A&R: Treatment of oral and facial manifestations of juvenile idiopathic arthritis, recommendations based on an interdisciplinary consensus

A&R: Treatment of oral and facial manifestations of juvenile idiopathic arthritis, recommendations based on an interdisciplinary consensus

 Last Update: 2022-09-06
 Source: Internet
 Author: User

Tags

terrasil tinea treatment

pediculosis treatment

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Background: Juvenile idiopathic arthritis (JIA) frequently involves the temporomandibular joint (TMJ)

Objectives: 1) To develop consensus-based, interdisciplinary recommendations for the management of orofacial manifestations in JIA

Methods: Recommendations were developed through an online survey of relevant patients, a systematic literature review, evidence-based recommendations generated during two consensus meetings, and iterations of Delphi research involving external experts

The course includes disciplines involved in the treatment of orofacial manifestations of JIA: paediatric rheumatology, radiology, orthodontics, oral and maxillofacial surgery, oral and facial pain specialists, and paediatric dentistry

RESULTS: Three general management principles and 12 interdisciplinary management recommendations for orofacial manifestations in JIA were outlined

Conclusion: This recommendation is the first interdisciplinary recommendation to guide the clinical management of TMJ-JIA

Source:

Stoustrup P, Resnick CM, Abramowicz S, et al.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

High Purity 99% BPN14770 Zatolmilast 1606974-33-7 In Stock Fast Ship to USA

CAS No.: 1606974-33-7

Pharm Grade

$1-1.1/UNIT FOB

High quality Thymosin α1 Pure CAS 62304-98-7 Thymosin Alpha 1 Thymalfasin

CAS No.: 62304-98-7

Pharmacy Grade

$12-15/UNIT FOB

Top quantity Imiquimod CAS NO 99011-02-6 White crystalline powder 99% API

CAS No.: 99011-02-6

Pharmacy Grade

$1800-1850/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.